W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY
|
Back to Search Results |
|
Catalog Number PAHR081002E |
Device Problems
Off-Label Use (1494); Insufficient Information (3190)
|
Patient Problem
Obstruction/Occlusion (2422)
|
Event Date 04/06/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
Patient information: the patient information was not provided.As the device remains implanted and the accessories were discarded on site, an evaluation of the device cannot be performed.(b)(4).A review of the manufacturing records indicated the lot met all pre-release manufacturing specifications.Ifu statement: in the ifu for the gore® viabahn® endoprosthesis with propaten bioactive surface the following was stated under the chapter warnings: the gore® viabahn® endoprosthesis with propaten bioactive surface is not indicated for use in the central circulatory system; such as, pulmonary arteries, aorta, coronary arteries, coronary bypass grafts, coronary sinus, carotid arteries, vertebral arteries, brachiocephalic (innominate) arteries, vena cavae or pulmonary veins.This event is considered as "off label-use".Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
|
|
Event Description
|
It was reported to gore that patient underwent endovascular treatment for a pseudo carotid aneurysm with a gore® viabahn® endoprosthesis with propaten bioactive surface (viabahn-device).It was stated that the procedure went well and during the final run the graft was found patent.It was reported that the following morning the patient had a stroke score of 20.He was transferred to another hospital to interventional radiology department for thrombectomy.It was stated that the stroke score was reduced to 6.
|
|
Event Description
|
Updated description: it was reported to gore that patient underwent endovascular treatment for a pseudo carotid aneurysm with a gore® viabahn® endoprosthesis with propaten bioactive surface (viabahn-device).It was stated that the procedure went well and during the final run the graft was found patent.It was reported that the following morning the patient had a stroke score of 20.He was transferred to another hospital to interventional radiology department for thrombectomy.It was stated that the stroke score was reduced to 6.The distributor stated that he was advised that the viabahn-device occluded after the procedure.The patient was transferred to another hospital for a thrombectomy.This is all the information he was provided.
|
|
Manufacturer Narrative
|
H6 evaluation codes investigation findings 213 refers to phr-review.Product investigation conclusion: the specific cause of this complaint could not be determined.Gore did not receive the explanted device, and information regarding the device form was not available.A product history review was conducted for the viabahn-device in this complaint, and the review of the manufacturing records, including the manufacturing, heparin coatings, and sterilization processes, indicated the lot met pre-release manufacturing specifications.The investigation confirms the complaint of occlusion, but the cause cannot be confirmed.B5 describe event or problem was updated.
|
|
Search Alerts/Recalls
|
|
|